Ultragenyx Pharmaceutical Inc. (RARE) stock
RARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.70+0.80 (+5.03%)
Close on Nov 17, 2026Market cap $1.65BP/E –Yield –
Ultragenyx Pharmaceutical enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Ultragenyx Pharmaceutical's enterprise value was $1.35B on Nov 11, 2026, against $2.93B a year earlier. Over the last 5 years it ranged from $1.19B to $4.98B, with a median of $2.74B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.35B | -24.4% |
| 2025 | Dec 31, 2025 | $1.79B | -45.0% |
| 2024 | Dec 31, 2024 | $3.26B | +8.4% |
| 2023 | Dec 29, 2023 | $3.01B | +27.6% |
| 2022 | Dec 30, 2022 | $2.36B | -52.6% |
| 2021 | Dec 31, 2021 | $4.98B | -35.0% |
| 2020 | Dec 31, 2020 | $7.65B | +294.6% |
| 2019 | Dec 31, 2019 | $1.94B | +14.5% |
| 2018 | Dec 31, 2018 | $1.69B | +5.9% |
| 2017 | Dec 29, 2017 | $1.60B | -33.9% |
| 2016 | Dec 30, 2016 | $2.42B | -38.1% |
| 2015 | Dec 31, 2015 | $3.91B | +226.6% |
| 2014 | Dec 31, 2014 | $1.20B | – |
See a number that looks wrong?